WW International's biggest risks in the FY2024 10-K
- Weight management competition and subscriber retention dominate WW International's risk profile following strategic pivots.
The risks most specific to WW International
- Risks Related to Our Business and Operations
Competition from other weight management and health and wellness industry participants or the development of more effective or more favorably perceived weight management methods could result in decreased demand for our services and products
Competition from other health and wellness participants or more effective weight management methods could reduce demand for our services and products.
- Risks Related to Our Business and Operations
A failure to continue to retain and grow our subscriber base could adversely affect our results of operations and business
Failure to retain and grow our subscriber base, which generates the predominant portion of our revenue, could adversely affect our operations.
- Risks Related to Our Business and Operations
We may not be able to successfully execute our business plan to be a leader in the rapidly evolving and increasingly competitive clinical weight management and weight loss market, which could adversely affect our business, financial condition or results of operations
We may fail to execute our business plan to lead in the rapidly evolving and competitive clinical weight management and weight loss market.
- Risks Related to Our Business and Operations
Our new compounded GLP-1 offering exposes us to a variety of risks that could result in an adverse impact on our reputation, business and ability to effectively compete
Our new compounded GLP-1 offering, sourced via a 503B outsourcing facility and dispensed by a 503A pharmacy, exposes us to reputational and competitive risks.
- Risks Related to Our Business and Operations
We may not be successful in evolving our in-person or virtual community offerings, including our workshop offering, which could adversely affect our business, brand, or financial results
Significant recruitment declines in our Workshops + Digital business and mix shift toward Digital have negatively impacted revenue.
- Risks Related to Our Business and Operations
We are undergoing a chief executive officer transition, which could cause disruption to our business or have an adverse impact on our operations and business strategy as well as the public or market perception of our business
Our CEO transition involving the departure of Sima Sistani could cause business disruption or adversely impact our strategy and public perception.
- Risks Related to Our Business and Operations
We may not successfully make acquisitions or enter into collaborations or joint ventures and we may not successfully integrate, operate or realize the anticipated benefits of such businesses
We may fail to successfully integrate or realize anticipated benefits from acquisitions, collaborations, or joint ventures like our 2023 Weekend Health acquisition.
- Risks Related to Our Liquidity
Our substantial amount of debt and our debt service obligations, as well as our exposure to variable rate indebtedness, could adversely affect our financial condition, and the restrictions of our debt covenants could impede our operations and flexibility
Our total debt of $1,445.0 million as of December 2024 and lack of future revolving credit availability could adversely affect our financial condition.
- Risks Related to Our Acquisition of Weekend Health, Inc. (d/b/a Sequence)
We have limited experience in the telehealth industry, which may hinder our ability to achieve the anticipated benefits of the Acquisition
Our limited experience in the highly regulated telehealth industry may hinder our ability to achieve the anticipated benefits of the Sequence acquisition.
All 42 risk factors
Headings as the filing states them, in filing order.
Risks Related to Our Business and Operations
- 01Competition from other weight management and health and wellness industry participants or the development of more effective or more favorably perceived weight management methods could result in decreased demand for our services and products
- 02A failure to continue to retain and grow our subscriber base could adversely affect our results of operations and business
- 03We may not be able to successfully execute our business plan to be a leader in the rapidly evolving and increasingly competitive clinical weight management and weight loss market, which could adversely affect our business, financial condition or results of operations
- 04If we do not continue to develop new, innovative services and products or if our services, products or brands do not continue to appeal to the market, or if we are unable to successfully expand into new channels of distribution or respond to consumer trends or sentiment, our business may suffer
- 05Our new compounded GLP-1 offering exposes us to a variety of risks that could result in an adverse impact on our reputation, business and ability to effectively compete
- 06We may not be able to successfully implement our strategic initiatives, which could adversely impact our business, financial conditions or results of operations
- 07We may not be successful in evolving our in-person or virtual community offerings, including our workshop offering, which could adversely affect our business, brand, or financial results
- 08Our business depends on the effectiveness and efficiency of our advertising and marketing programs across multiple platforms, including the strength of our social media presence, to attract and retain members and subscribers
- 09Our reputation could be impaired due to actions taken by our franchisees, licensees, suppliers, affiliated provider entities, PCs’ healthcare professionals, and other partners
- 10We have in the past and may in the future be required to recognize asset impairment charges for indefinite- and definite-lived assets
- 11Loss of key personnel, strategic partners or consultants or failure to effectively manage and motivate our workforce could negatively impact our sales of services and products, business, financial condition and results of operations
- 12We are undergoing a chief executive officer transition, which could cause disruption to our business or have an adverse impact on our operations and business strategy as well as the public or market perception of our business
- 13We may not successfully make acquisitions or enter into collaborations or joint ventures and we may not successfully integrate, operate or realize the anticipated benefits of such businesses
- 14The seasonal nature of our business could cause our operating results to fluctuate
- 15If we do not maintain effective internal control over financial reporting, we could fail to report our financial results accurately
- 16Any event that impedes accessing resources or discourages or impedes people from gathering with others, whether at a gathering place, work or otherwise, could adversely affect our business
- 17Early termination by us of leases could have an adverse impact on our financial results
- 18The inability to renew certain of our licenses, or the inability to do so on terms that are favorable to us, could have an adverse effect on our financial results
Risks Related to Our Liquidity
- 19Our substantial amount of debt and our debt service obligations, as well as our exposure to variable rate indebtedness, could adversely affect our financial condition, and the restrictions of our debt covenants could impede our operations and flexibility
- 20Our credit facilities and the indenture governing our notes permit us to incur additional indebtedness in the future. If we incur additional indebtedness, the risks we face as a result of our leverage could intensify
- 21We may not be able to generate sufficient cash to service all of our debt and satisfy our other liquidity requirements
Risks Related to Technology, Security and Intellectual Property
- 22Any failure of our technology or systems to perform satisfactorily could result in an adverse impact on our business
- 23Our reputation and the appeal of our services and products may be harmed by data security breaches and other malicious acts or privacy concerns
- 24Integration of artificial intelligence into our offerings and our use of artificial intelligence in our operations could adversely affect our business or results of operations
- 25Third parties may infringe on our brands and other intellectual property rights, which may have an adverse impact on our business
- 26We may be subject to intellectual property rights claims
Risks Related to Laws and Regulations, Litigation, and Our International Operations
- 27Our business is subject to legislative and regulatory restrictions
- 28A number of laws and regulations govern our advertising and marketing, services, products, operations and relations with consumers, licensees, franchisees, coaches, guides, employees and government authorities in the countries in which we operate
- 29For additional information regarding the legislative and regulatory restrictions applicable to our Clinical business, see our other Risk Factors regarding our Clinical business
- 30The healthcare laws and regulations to which we are subject are constantly evolving and may change significantly in the future
- 31We may be subject to extensive fraud, waste, and abuse laws that may give rise to federal and state audits and investigations, including actions for false and other improper claims
- 32Outcomes of litigation or regulatory actions could adversely impact our financial condition
- 33Our international operations expose us to regulatory, economic, political, social and intellectual property risks in the countries in which we operate, which risks may be exacerbated as a result of war and terrorism
- 34We are exposed to foreign currency risks from our international operations that could adversely affect our financial results
Risks Related to Our Acquisition of Weekend Health, Inc. (d/b/a Sequence)
- 35The Acquisition may not achieve its intended results
- 36greater than anticipated costs related to the integration of Sequence’s business and operations into ours
- 37The Acquisition may not be accretive, and may continue to be dilutive, to our earnings per share, which may negatively affect the market price of shares of our common stock
- 38We have limited experience in the telehealth industry, which may hinder our ability to achieve the anticipated benefits of the Acquisition
- 39Notwithstanding the due diligence investigation that we performed in connection with our entry into the Merger Agreement, Sequence may have liabilities, losses, or other exposures for which we do not have adequate insurance coverage, indemnification, or other protection
Risks Related to Ownership of Our Common Stock
- 40Our articles of incorporation and bylaws and Virginia corporate law contain provisions that may discourage a takeover attempt
- 41We could fail to maintain the listing of our common stock on Nasdaq, which could seriously harm the liquidity of our stock and our ability to raise capital or complete a strategic transaction
- 42Actions of activist shareholders could adversely impact our business and cause us to incur significant expenses
Other WW International 10-Ks
- FY2025 10-K risk factors38 risks7 new11 dropped9 reworded
WW International recently emerged from Chapter 11 bankruptcy, discharging debt and reconstituting its Board and leadership.
Filed Mar 16, 2026
About this page
The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.